328 related articles for article (PubMed ID: 28752467)
1. Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency.
Gruntman AM; Flotte TR
Methods Mol Biol; 2017; 1639():267-275. PubMed ID: 28752467
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency.
Song CQ; Wang D; Jiang T; O'Connor K; Tang Q; Cai L; Li X; Weng Z; Yin H; Gao G; Mueller C; Flotte TR; Xue W
Hum Gene Ther; 2018 Aug; 29(8):853-860. PubMed ID: 29597895
[TBL] [Abstract][Full Text] [Related]
4. Alpha1-antitrypsin deficiency: from genotype to childhood disease.
Marcus N; Teckman JH; Perlmutter DH
J Pediatr Gastroenterol Nutr; 1998 Jul; 27(1):65-74. PubMed ID: 9669729
[No Abstract] [Full Text] [Related]
5. Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype.
Bjursell M; Porritt MJ; Ericson E; Taheri-Ghahfarokhi A; Clausen M; Magnusson L; Admyre T; Nitsch R; Mayr L; Aasehaug L; Seeliger F; Maresca M; Bohlooly-Y M; Wiseman J
EBioMedicine; 2018 Mar; 29():104-111. PubMed ID: 29500128
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 Antitrypsin Deficiency as a Candidate for Gene Editing.
Flotte TR
Hum Gene Ther; 2018 Aug; 29(8):843-844. PubMed ID: 30096037
[No Abstract] [Full Text] [Related]
7. Emerging Concepts and Human Trials in Alpha-1-Antitrypsin Deficiency Liver Disease.
Teckman JH
Semin Liver Dis; 2017 May; 37(2):152-158. PubMed ID: 28564723
[No Abstract] [Full Text] [Related]
8. Advances in Alpha-1 Antitrypsin Gene Therapy.
Lorincz R; Curiel DT
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):560-570. PubMed ID: 32668173
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for alpha-1 antitrypsin deficiency: an update.
Pires Ferreira D; Gruntman AM; Flotte TR
Expert Opin Biol Ther; 2023 Mar; 23(3):283-291. PubMed ID: 36825473
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
Greene CM; Miller SD; Carroll T; McLean C; O'Mahony M; Lawless MW; O'Neill SJ; Taggart CC; McElvaney NG
J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-antitrypsin deficiency: current concepts.
Mulgrew AT; Taggart CC; McElvaney NG
Lung; 2007; 185(4):191-201. PubMed ID: 17562108
[TBL] [Abstract][Full Text] [Related]
12. Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches.
Ghosh AJ; Hobbs BD
Expert Rev Respir Med; 2022 Feb; 16(2):173-182. PubMed ID: 35025710
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations of alpha 1-antitrypsin deficiency.
Perlmutter DH
Gastroenterol Clin North Am; 1995 Mar; 24(1):27-43. PubMed ID: 7729860
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
Lachaux A; Dumortier J
Rev Mal Respir; 2014 Apr; 31(4):357-64. PubMed ID: 24750955
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin deficiency: current therapy and emerging targets.
McElvaney OF; Fraughen DD; McElvaney OJ; Carroll TP; McElvaney NG
Expert Rev Respir Med; 2023 Mar; 17(3):191-202. PubMed ID: 36896570
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiency.
Packer MS; Chowdhary V; Lung G; Cheng LI; Aratyn-Schaus Y; Leboeuf D; Smith S; Shah A; Chen D; Zieger M; Cafferty BJ; Yan B; Ciaramella G; Gregoire FM; Mueller C
Mol Ther; 2022 Apr; 30(4):1396-1406. PubMed ID: 35121111
[TBL] [Abstract][Full Text] [Related]
17. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
18. Current status of gene therapy for α-1 antitrypsin deficiency.
Loring HS; Flotte TR
Expert Opin Biol Ther; 2015 Mar; 15(3):329-36. PubMed ID: 25363251
[TBL] [Abstract][Full Text] [Related]
19. Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy.
Strange C
Respir Care; 2018 Jun; 63(6):690-698. PubMed ID: 29794204
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-antitrypsin deficiency: diagnosis and treatment.
Perlmutter DH
Clin Liver Dis; 2004 Nov; 8(4):839-59, viii-ix. PubMed ID: 15464658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
